Biocytogen provides one-stop solutions to preclinical efficacy and safety evaluation services, in a bid to expedite the preclinical drug discovery and development for global pharma and biotech companies. Our scientists are well-versed in in vivo efficacy, PK/PD, toxicity, in vitro assays, and other high quality studies, arriving at a wide array of end points or outcomes. We also keep our customers updated of the study progress, presenting detailed reports at the end of studies. At Biocytogen, we value client trust, committed to achieving 100% customer satisfaction.